USD 0.04
(12.39%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.73 Million USD | -19.2% |
2022 | 2.14 Million USD | 19.19% |
2021 | 1.79 Million USD | -39.39% |
2020 | 2.96 Million USD | 638.82% |
2019 | 401.34 Thousand USD | 418.44% |
2018 | 77.41 Thousand USD | -25.09% |
2017 | 103.34 Thousand USD | -41.07% |
2016 | 175.36 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 275.64 Thousand USD | -19.38% |
2023 Q4 | 341.89 Thousand USD | -33.25% |
2023 Q3 | 512.2 Thousand USD | 8.58% |
2023 Q1 | 404.9 Thousand USD | -50.7% |
2023 Q2 | 471.74 Thousand USD | 16.51% |
2023 FY | 1.73 Million USD | -19.2% |
2022 Q2 | 425.36 Thousand USD | -14.98% |
2022 FY | 2.14 Million USD | 19.19% |
2022 Q4 | 821.38 Thousand USD | 107.92% |
2022 Q3 | 395.04 Thousand USD | -7.13% |
2022 Q1 | 500.28 Thousand USD | -44.19% |
2021 Q3 | 484.11 Thousand USD | 146.57% |
2021 Q1 | 220.34 Thousand USD | -88.0% |
2021 Q2 | 196.33 Thousand USD | -10.89% |
2021 Q4 | 896.36 Thousand USD | 85.16% |
2021 FY | 1.79 Million USD | -39.39% |
2020 FY | 2.96 Million USD | 638.82% |
2020 Q4 | 1.83 Million USD | 0.0% |
2019 FY | 401.34 Thousand USD | 418.44% |
2018 FY | 77.41 Thousand USD | -25.09% |
2017 Q4 | 402.38 USD | 0.0% |
2017 FY | 103.34 Thousand USD | -41.07% |
2016 FY | 175.36 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Medical Technologies Inc. | 2.86 Million USD | 39.554% |
Ansell Limited | 495.5 Million USD | 99.651% |
Ansell Limited | 495.5 Million USD | 99.651% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 82.8 Million USD | 97.91% |
BioLife Sciences Inc. | - USD | -Infinity% |
Psykey, Inc. | 1.21 Million USD | -42.627% |
ConvaTec Group Plc | 910.31 Million USD | 99.81% |
ConvaTec Group Plc | 872.5 Million USD | 99.802% |
Encision Inc. | 3.77 Million USD | 54.173% |
Golden Valley Development, Inc | 141.81 Thousand USD | -1120.467% |
Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -1474.402% |
Innovative MedTech Inc. | 6.09 Million USD | 71.622% |
LifePoint, Inc. | 7.42 Million USD | 76.687% |
Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 72.74% |
Paradigm Medical Industries, Inc. | 855 Thousand USD | -102.428% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 726.13 Thousand USD | -138.352% |
Reflect Scientific, Inc. | 1.06 Million USD | -62.711% |
SmileDirectClub, Inc. | 517 Million USD | 99.665% |
Sector 10, Inc. | 39.84 Thousand USD | -4243.831% |
Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.974% |
SheerVision, Inc. | 2.33 Million USD | 25.771% |
United Health Products, Inc. | 2.42 Million USD | 28.674% |
Vasamed, Inc. | 4.67 Million USD | 62.962% |
Wearable Health Solutions, Inc. | 2.56 Million USD | 32.44% |
Yubo International Biotech Limited | 1.25 Million USD | -37.594% |